Aflac
About: Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
Employees: 12,694
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
50% more call options, than puts
Call options by funds: $427M | Put options by funds: $284M
41% more first-time investments, than exits
New positions opened: 158 | Existing positions closed: 112
1% more funds holding
Funds holding: 1,525 [Q3] → 1,535 (+10) [Q4]
0.37% less ownership
Funds ownership: 67.13% [Q3] → 66.76% (-0.37%) [Q4]
4% less capital invested
Capital invested by funds: $42B [Q3] → $40.1B (-$1.85B) [Q4]
14% less repeat investments, than reductions
Existing positions increased: 494 | Existing positions reduced: 572
23% less funds holding in top 10
Funds holding in top 10: 30 [Q3] → 23 (-7) [Q4]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Morgan Stanley Nigel Dally 70% 1-year accuracy 7 / 10 met price target | 4%downside $105 | Equal-Weight Maintained | 28 Feb 2025 |
Wells Fargo Elyse Greenspan 69% 1-year accuracy 82 / 119 met price target | 7%downside $102 | Equal-Weight Maintained | 19 Feb 2025 |
Keefe, Bruyette & Woods Ryan Krueger 81% 1-year accuracy 17 / 21 met price target | 5%downside $104 | Market Perform Maintained | 12 Feb 2025 |
Barclays Alex Scott 53% 1-year accuracy 42 / 79 met price target | 13%downside $95 | Underweight Maintained | 7 Feb 2025 |
Piper Sandler John Barnidge 73% 1-year accuracy 35 / 48 met price target | 7%upside $118 | Overweight Maintained | 7 Feb 2025 |
Financial journalist opinion
Based on 7 articles about AFL published over the past 30 days









